Nathan Rich
Stock Analyst
(1.33)
# 973
Out of 4,648 analysts
89
Total ratings
34.92%
Success rate
-10.5%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $18.09 | +16.09% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $175.18 | +11.88% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $23.34 | +28.53% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $8.41 | -4.88% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $21.28 | -17.76% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $255.55 | +50.66% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $12.56 | +11.46% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical | Maintains: Neutral | $10 → $11 | $18.64 | -40.99% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $210.78 | +6.75% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $414.52 | +56.81% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $30 | $21.04 | +42.59% | 5 | Dec 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $54.65 | +61.02% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $13.29 | -9.71% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $72.33 | +17.52% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $11.45 | -3.93% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $330.66 | +1.31% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $557.77 | -4.08% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $18.09
Upside: +16.09%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $175.18
Upside: +11.88%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $23.34
Upside: +28.53%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $8.41
Upside: -4.88%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $21.28
Upside: -17.76%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $255.55
Upside: +50.66%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $12.56
Upside: +11.46%
Teva Pharmaceutical
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $18.64
Upside: -40.99%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $210.78
Upside: +6.75%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $414.52
Upside: +56.81%
Dec 1, 2023
Maintains: Neutral
Price Target: $35 → $30
Current: $21.04
Upside: +42.59%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $54.65
Upside: +61.02%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $13.29
Upside: -9.71%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $72.33
Upside: +17.52%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $11.45
Upside: -3.93%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $330.66
Upside: +1.31%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $557.77
Upside: -4.08%